Abuse of medications for the treatment of migraines: results of an online survey
- Authors: Koval'chuk N.A.1, Shagbazian A.E.1, Tabeeva G.R.1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 23, No 11 (2021)
- Pages: 847-851
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/96616
- DOI: https://doi.org/10.26442/20751753.2021.11.201146
- ID: 96616
Cite item
Full Text
Abstract
Background. The abuse of headache medications is an important factor in the formation of drug-induced headache.
Aim. To determine the prevalence and nature of drug use among patients with migraine and chronic cephalgic syndrome.
Materials and methods. An Internet survey was conducted among 1598 Internet users, as well as through social networks (Instagram, Facebook, VK) using Google Forms.
Results. 60% of respondents with chronic headache and migraine symptoms did not have a reliable diagnosis. More than 70% of patients choose a drug for pain relief on their own and 62.7% take the drug in every headache attack.
Conclusion. Among patients with chronic headaches and migraines, there is a high percentage of people abusing symptomatic drugs, which indicates a high risk of drug-induced headache formation.
Full Text
##article.viewOnOriginalSite##About the authors
Nadezhda A. Koval'chuk
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: kowalchuk.n.a@gmail.com
ORCID iD: 0000-0002-8437-7205
Graduate Student
Russian Federation, MoscowAnait E. Shagbazian
Sechenov First Moscow State Medical University (Sechenov University)
Email: kowalchuk.n.a@gmail.com
ORCID iD: 0000-0003-2561-5944
Graduate Student
Russian Federation, MoscowGiuzial R. Tabeeva
Sechenov First Moscow State Medical University (Sechenov University)
Email: kowalchuk.n.a@gmail.com
ORCID iD: 0000-0002-3833-532X
D. Sci. (Med.), Prof.
Romania, MoscowReferences
- Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12:575-83. doi: 10.1038/nrneurol.2016.124
- Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010;9:391-401. doi: 10.1016/S1474-4422(10)70008-9
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders ICHD-3, 3rd edition. Cephalalgia. 2018;38:1-211.
- Westergaard ML, Hansen EH, Glümer C, et al. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34(6):409-25. doi: 10.1177/0333102413512033
- Aaseth K, Grande RB, Kvaerner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30–44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008;28:705-13. doi: 10.1111/j.1468-2982.2008.01577.x
- Ayzenberg I, Katsarava Z, Sborowski A, et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012;32(5):373-81. doi: 10.1177/0333102412438977, PMID: 22395797
- Find NL, Terlizzi R, Munksgaard SB, et al. Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study. J Headache Pain. 2015;17:20. doi: 10.1186/s10194-016-0612-2, PMID: 26957090, PMCID: PMC4783306
- Bendtsen L, Munksgaard S, Tassorelli C, et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014;34(6):426-33. doi: 10.1177/0333102413515338, PMID: 24322480
- Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al. Headache characteristics and burden from chronic migraine with medication overuse headache: cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache. 2021;61(2):351-62. doi: 10.1111/head.14056, PMID: 33432635
- Schwedt TJ, Buse DC, Argoff CE, et al. Medication Overuse and Headache Burden Results From the CaMEO Study. Neurol Clin Pract. 2021;11(3):216-26. doi: 10.1212/CPJ.0000000000001037
- Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005;25(1):12-5. doi: 10.1111/j.1468-2982.2004.00789.x, PMID: 15606564
- Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019;18(9):891-902. doi: 10.1016/S1474-4422(19)30146-2, PMID: 31174999
- Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61(3):375-82. doi: 10.1212/01.wnl.0000078940.53438.83, PMID: 12913201
- Vandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018;19(1):50. doi: 10.1186/s10194-018-0875-x, PMID: 30003412, PMCID: PMC6043466
- Мербаум П.А., Табеева Г.Р., Сергеев А.В. Лекарственно-индуцированная головная боль: анализ терапевтических стратегий. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):25-31 [Merbaum PA, Tabeeva GR, Sergeev AV. Drug-induced headache: an analysis of therapeutic strategies. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2020;12(4):25-31 (in Russian)]. doi: 10.14412/2074-2711-2020-4-25-31
- Rapoport AM. Medication overuse headache: awareness, detection and treatment. CNS Drugs. 2008;22:995-1004. doi: 10.2165/0023210-200822120-00003
- Brusa P, Allais G, Scarinzi C, et al. Self-medication for migraine: A nationwide cross-sectional study in Italy. PLoS One. 2019;14(1):e0211191. doi: 10.1371/journal.pone.0211191, PMID: 30673780, PMCID: PMC6343913
- Mehuys E, Paemeleire K, Van Hees T, et al. Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol. 2012;19:1093-9. doi: 10.1111/j.1468-1331.2012.03681.x
- Hedenrud T, Babic N, Jonsson P. Medication overuse headache: selfperceived and actual knowledge among pharmacy staff. Headache. 2014;54:1019-25. doi: 10.1111/head.12350
- Carlsen LN, Westergaard ML, Bisgaard M, et al. National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia. 2018;38(7):1316-25. doi: 10.1177/0333102417736898
- Westergaard ML, Hansen EH, Glumer C, Jensen RH. Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse. Eur J Clin Pharmacol. 2015;71:851-60. doi: 10.1007/s00228-015-1858-3
- Brusa P, Allais G, Scarinzi C, et al. Self-medication for migraine: A nationwide cross-sectional study in Italy. PLoS One. 2019;14(1):e0211191. doi: 10.1371/journal.pone.0211191, PMID: 30673780, PMCID: PMC6343913
- Negro A, Curto M, Lionetto L, et al. A critical evaluation on MOH current treatments. Curr Treat Options Neurol. 2017;19:32. doi: 10.1007/s11940-017-0465-2
- Westergaard ML, Glümer C, Hansen EH, Jensen RH. Medication overuse, healthy lifestyle behaviour and stress in chronic headache: results from a population-based representative survey. Cephalalgia. 2016;36:15-28. doi: 10.1177/0333102415578430
- Rossi P, Di Lorenzo C, Faroni J, et al. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26:1097-105. doi: 10.1111/j.1468-2982.2006.01175.x
- Jonsson P, Linde M, Hensing G, Hedenrud T. Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain. 2012;13:281-90. doi: 10.1007/s10194-012-0432-y
- Bekkelund SI, Salvesen R. Patient satisfaction with a neurological specialist consultation for headache. Scand J Prim Health Care. 2002;20:157-60. doi: 10.1080/028134302760234609
- Lai JT, Dereix JD, Ganepola RP, et al. Should we educate about the risks of medication overuse headache? J Headache Pain. 2014;15:10. doi: 10.1186/1129-2377-15-10
- Grande RB, Aaseth K, Benth JS, et al. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2011;18:129-37. doi: 10.1111/j.1468-1331.2010.03094.x
- Fritsche G, Frettlöh J, Hüppe M, et al. Prevention of medication overuse in patients with migraine. Pain. 2010;151:404-13. doi: 10.1016/j.pain.2010.07.032
- Kristoffersen ES, Straand J, Vetvik KG, et al. Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry. 2015;86:505-12. doi: 10.1136/jnnp-2014-308548
- Rossi P, Faroni JV, Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol. 2011;18:396-401. doi: 10.1111/j.1468-1331.2010.03157.x
- Lagman-Bartolome AM, Lawler V, Lay C. Headache education active-waiting directive: a program to enhance well-being during long referral wait times. Headache. 2018;58:109-17. doi: 10.1111/head.13194
- Шагбазян А.Э., Ковальчук Н.А., Табеева Г.Р. Роль образовательных программ в ведении пациентов с медикаментозно-индуцированной головной болью. Неврология, нейропсихиатрия, психосоматика. 2021;13(3):27-33 [Shagbazyan AE, Kovalchuk NA, Tabeeva GR. Role of educational programs in management of patients with medicationoveruse headache. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2021;13(3):27-33 (in Russian)]. doi: 10.14412/2074-2711-2021-3-27-33
- Diener HC, Holle D, Dresler T, Gaul C. Chronic headache due to overuse of analgesics and anti-migraine agents. Dtsch Arztebl Int. 2018;115:365-70. doi: 10.3238/arztebl.2018.0365
Supplementary files
